Closing the CRM value gap in pharma: From dashboards to P&L impact

Pharma’s CRM moment is here. Platforms are more advanced, analytics more sophisticated and AI pilots increasingly common. Yet for many organizations, the business impact still falls short of the ambition.

Join us for this candid session to explore three patterns that consistently limit value realization: implementations that optimize the platform but miss the underlying business model shift; efficiency and engagement gains that improve dashboards but don’t translate to the profit and loss (P&L) statement; and systems built precisely for today’s requirements, even as tomorrow’s context is already evolving.

We’ll examine how leading organizations are approaching CRM differently, with a clearer focus on connecting technology investment to measurable commercial outcomes.

By attending, you’ll learn:

• The three most common value-leakage patterns in CRM programs, and how to identify them early
• Why KPI improvements and workflow gains often fail to translate into financial impact
• What companies can do differently to turn CRM investment into measurable commercial outcomes